A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

J Kuhle 1, 2 M Hardmeier 1 G Disanto 2, 3 K Gugleta 1 M Ecsedi 1 C Lienert 4 Mp Amato 5 K Baum 6 M Buttmann 7 A Bayas 8 David Brassat 8 B Brochet 9, 10 C Confavreux 11 Gilles Edan 12, 13 M Färkkilä 14 S Fredrikson 15 M Frontoni 16 M D’hooghe 17 M Hutchinson 18 J de Keyser 19 Bc Kieseier 20 T Kümpfel 21 J Rio 22 C Polman 23 E Roullet 24 Claude Stolz 25 K Vass 26 Kp Wandinger 27 L Kappos 1, 28
Abstract : To explore long-term effects of treatment and prognostic relevance of variables assessed at baseline and during the European secondary progressive multiple sclerosis (SPMS) trial of interferon beta 1b (IFNB-1b).
Document type :
Journal articles
Liste complète des métadonnées

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01201949
Contributor : Laurent Jonchère <>
Submitted on : Friday, September 18, 2015 - 1:50:26 PM
Last modification on : Tuesday, April 2, 2019 - 1:59:59 AM

Links full text

Identifiers

Citation

J Kuhle, M Hardmeier, G Disanto, K Gugleta, M Ecsedi, et al.. A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.. Multiple Sclerosis, SAGE Publications, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩. ⟨hal-01201949⟩

Share

Metrics

Record views

410